Literature DB >> 18923738

Directly observed therapy with azithromycin for skin and soft tissue infections in injection drug users.

Harout K Tossonian1, Brian Conway, Jesse D Raffa, Mark Viljoen, Milan Khara, Annabel Mead, Heather Culbert, Stanley Devlaming.   

Abstract

Entities:  

Year:  2007        PMID： 18923738      PMCID： PMC2533629          DOI： 10.1155/2007/328074

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  6 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Enhancing adherence to HAART: a pilot program of modified directly observed therapy.

Authors:  M S Stenzel; M McKenzie; J A Mitty; T P Flanigan
Journal:  AIDS Read       Date:  2001-06

3.  Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland.

Authors:  C Scheidegger; W Zimmerli
Journal:  Rev Infect Dis       Date:  1989 May-Jun

4.  The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.

Authors:  Jennifer A Mitty; Grace E Macalino; Lauri B Bazerman; Helen G Loewenthal; Joseph W Hogan; Cynthia J MacLeod; Timothy P Flanigan
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-15       Impact factor: 3.731

5.  Injecting-related harm and treatment-seeking behaviour among injecting drug users.

Authors:  A Morrison; L Elliott; L Gruer
Journal:  Addiction       Date:  1997-10       Impact factor: 6.526

6.  Once-daily azithromycin in the treatment of adult skin and skin-structure infections.

Authors:  G Amaya-Tapia; G Aguirre-Avalos; J Andrade-Villanueva; G Peredo-González; R Morfín-Otero; S Esparza-Ahumada; E Rodríguez-Noriega
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.